<DOC>
	<DOCNO>NCT01826162</DOCNO>
	<brief_summary>Gut microbiota increasingly recognize important factor fat distribution , insulin sensitivity glucose lipid metabolism . Accordingly , intestinal microbiota could play important role development obesity type 2 diabetes mellitus . The role gut-derived short-chain fatty acid ( SCFA ) , formation enhance microbial fermentation fibre , still controversial . At present time , understanding effect SCFA human metabolism ( gut systemically ) still limit . The investigator hypothesize differential availability SCFA impact human metabolism differently . In placebo control , double-blind , randomize crossover pilot study investigator validate overweight/obese healthy male volunteer whether rectal administration SCFA good model study acute metabolic effect SCFA . For , investigate site administration ( distal proximal colon ) SCFA differentially affect parameter substrate energy metabolism test duration short-term effect SCFA administration .</brief_summary>
	<brief_title>Short Chain Fatty Acid Metabolism Energy Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Overweight , obese men athletes diabetes mellitus</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>